| |
 |
Editorial [Hot Topic: Bilirubin Induced Neurological Damage: From the Cell to the Newborn (Executive Editor: J.D. Ostrow and C. Tiribelli)]
|
| |
|
pp.2868-2868 (1) Authors: J. Donald Ostrow, Claudio Tiribelli
|
| |
|
|
| |
|
Bilirubin Chemistry and Metabolism; Harmful and Protective Aspects
|
| |
|
pp.2869-2883 (15) Authors: Libor Vitek, J. Donald Ostrow
|
| |
|
|
| |
|
The Role of ABC Transporters in Protecting Cells from Bilirubin Toxicity
|
| |
|
pp.2884-2892 (9) Authors: C. Bellarosa, G. Bortolussi, C. Tiribelli
|
| |
|
|
| |
|
Blood-Brain Interfaces and Bilirubin-Induced Neurological Diseases
|
| |
|
pp.2893-2907 (15) Authors: J. F. Ghersi-Egea, S. Gazzin, N. Strazielle
|
| |
|
|
| |
|
Redox State, Oxidative Stress, and Molecular Mechanisms of Protective and Toxic Effects of Bilirubin on Cells
|
| |
|
pp.2908-2914 (7) Authors: Gianluca Tell, Stefano Gustincich
|
| |
|
|
| |
|
Contribution of Inflammatory Processes to Nerve Cell Toxicity by Bilirubin and Efficacy of Potential Therapeutic Agents
|
| |
|
pp.2915-2926 (12) Authors: Adelaide Fernandes, Dora Brites
|
| |
|
|
| |
|
Pharmacological Therapies for Unconjugated Hyperbilirubinemia
|
| |
|
pp.2927-2938 (12) Authors: F.J. C. Cuperus, A. M. Hafkamp, C. V. Hulzebos, H. J. Verkade
|
| |
|
|
| |
|
Intervention Guidelines for Neonatal Hyperbilirubinemia: An Evidence Based Quagmire
|
| |
|
pp.2939-2945 (7) Authors: Richard P. Wennberg, Charles E. Ahlfors, Aleksandr Y. Aravkin
|
| |
|
|
| |
|
Polysulfated/Sulfonated Compounds for the Development of Drugs at the Crossroad of Viral Infection and Oncogenesis
|
| |
|
pp.2946-2957 (12) Authors: Marco Rusnati, Chiara Urbinati
|
| |
|
|
| |
|
Dendrimers: A Class of Polymers in the Nanotechnology for the Delivery of Active Pharmaceuticals
|
| |
|
pp.2958-2969 (12) Authors: Abdus Samad, Md. Intakhab Alam, Kinshuk Saxena
|
| |
|
|
| |
|
Hybrid Drugs for Malaria
|
| |
|
pp.2970-2985 (16) Authors: J. J. Walsh, A. Bell
|
| |
|
|
